GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Common Stock

Kaken Pharmaceutical Co (TSE:4521) Common Stock : 円23,853 Mil (As of Sep. 2024)


View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Common Stock?

Kaken Pharmaceutical Co's quarterly common stock declined from Mar. 2024 (円23,853 Mil) to Jun. 2024 (円0 Mil) but then increased from Jun. 2024 (円0 Mil) to Sep. 2024 (円23,853 Mil).

Kaken Pharmaceutical Co's annual common stock stayed the same from Mar. 2022 (円23,853 Mil) to Mar. 2023 (円23,853 Mil) and stayed the same from Mar. 2023 (円23,853 Mil) to Mar. 2024 (円23,853 Mil).


Kaken Pharmaceutical Co Common Stock Historical Data

The historical data trend for Kaken Pharmaceutical Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Common Stock Chart

Kaken Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23,853.00 23,853.00 23,853.00 23,853.00 23,853.00

Kaken Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23,853.00 23,853.00 - 23,853.00 23,853.00

Kaken Pharmaceutical Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Kaken Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650
Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co Headlines

No Headlines